Where innovative Medical Go-To-Market Success is the rule! 

Want to Learn or See More? Click here

Synergistic Marketing, founded in 1990 by Mark Lutvak, is a successful, growing and profitable sales and marketing contracting firm and consultancy. We are dedicated to serving Small Emerging businesses that own or possess Medical Technology or Medical Device IP. We support our clients with a go-to-market strategy that takes advantage of our extensive network of medical industry companies as well as our extensive list of contacts who are our Corporate Partners.

Want to Learn or See More? Click here


Medical Technology and Device News Title

  • October 7, 2016:

    The first commercial HeartLight procedure was successfully performed on September 26 by Srinivas R. Dukkipati, M.D., director of the electrophysiology lab and co-director of cardiac arrhythmia services at Mount Sinai Hospital. The HeartLight system received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) in April and is an endoscopic ablation system for the treatment of patients with paroxysmal atrial fibrillation.Full Story

  • October 6, 2016:

    Spinal cord stimulation (SCS) therapy using BurstDR from St. Jude Medical (recently FDA Approved) can transform quality of life for many people who are otherwise unable to find relief from chronic pain. BurstDR stimulation from St. Jude Medical has been clinically proven to improve upon traditional SCS by generating superior pain relief. Full Story

  • September 8, 2016:

    Medtronics announced U.S. Food and Drug Administration (FDA) clearance of the StealthStation application, which integrates pre-operative planning, intraoperative imaging to help guide surgeons during cranial procedures, is designed to improve procedural workflow and allow for Deep Brain Stimulation (DBS) lead placement with a high level of accuracy.Full Story

  • September 27, 2016:

    BrainScope Company, Inc. announced that the United States Food and Drug Administration (FDA) cleared the company to market the Ahead 300. Developed in partnership with the U.S. Department of Defense, the Ahead 300 offers clinicians a comprehensive panel of data to assist in their diagnosis of the full spectrum of Traumatic Brain Injury (TBI), including concussion. Full Story

  • September 21, 2016:

    A new Mayo Clinic study in JAMA Neurology shows that epileptic seizures were suppressed with continuous electrical stimulation in patients who hadn't responded to other treatments. In the study, a grid of electrical contacts was used for stimulation at levels the patient would not notice. If the stimulation provided clinical benefit to the patient, this temporary grid was replaced with more permanent contacts that could offer continuous stimulation.
    Within minutes of initiating stimulation, ten of the 13 patients, 77 percent, reported improvement for both epilepsy severity and life satisfaction. The majority of patients experienced more than 50 percent reduction in seizures, and 44 percent were free of disabling seizures. Full Story